SCHEMBL26435332

SCHEMBL26435332

c1ccc2cc(-c3ccc(-c4nc(-c5ccc6c(c5)sc5ccccc56)nc(-c5cccc6ccc7ccccc7c56)n4)cc3)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 8/20 0.35
S1PR4 O95977 6/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PIM1 P11309 1/20 0.34
ALOX5 P09917 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
GPR3 P46089 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
RAC1 P63000 1/20 0.32
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
MCL1 Q07820 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435354 0.96 ALDH1A1 (0.36) S1PR5S1PR4ALDH1A1MAPTHPGD
SCHEMBL26047883 0.96 S1PR5 (0.34) S1PR5S1PR4ALDH1A1MAPTHPGD
SCHEMBL25817919 0.93 F9 (0.34) S1PR5S1PR4ALDH1A1MAPTHPGD
SCHEMBL26435396 0.93 ALDH1A1 (0.34) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL26435357 0.93 ALDH1A1 (0.34) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL26271497 0.92 PIM1 (0.38) S1PR5S1PR4ALDH1A1MAPTHPGD
SCHEMBL26047770 0.91 S1PR5 (0.36) S1PR5S1PR4ALDH1A1MAPTHPGD
SCHEMBL26435331 0.91 F9 (0.37) S1PR5S1PR4ALDH1A1MAPTHPGD
SCHEMBL24342536 0.90 S1PR5 (0.39) S1PR5S1PR4ALDH1A1MAPTHPGD
SCHEMBL26048037 0.90 SMN1; SMN2 (0.36) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 S1PR5 4840/4885S1PR4 4830/4885ALDH1A1 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.